Maplelane Capital’s IPG Photonics IPGP Stock Holding History

Maplelane Capital’s Portfolio IPGP Stock Details IPGP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-1	Closed	-$139	–	145
2019 Q3	$0	Buy	+1	New	+$132	﹤0.01%	139
2016 Q1	–	Sell	-1	Closed	–	–	116
2015 Q4	$0	Hold	1	–	–	﹤0.01%	124
2015 Q3	$0	Hold	1	–	–	﹤0.01%	120
2015 Q2	$0	Buy	+1	New	+$94	﹤0.01%	174

Other funds holding IPGP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

PAMU

Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Maplelane Capital's IPGP Position: Q4 2019 in Review

Maplelane Capital sold out of IPG Photonics (IPGP) in Q4 2019, closing a stake of 1 share — an estimated $139 sold.

Maplelane Capital first reported a position in IPGP in Q2 2015 and held it in 4 quarters. The position peaked at $0 in Q3 2019. 427 funds tracked by Wall St. Rank hold IPGP as of Q4 2019.

Maplelane Capital reported no remaining IPG Photonics position as of Q4 2019 after selling out during the quarter.
Maplelane Capital sold 1 IPG Photonics share in Q4 2019, an estimated $139.
Maplelane Capital first reported a position in IPG Photonics in Q2 2015 and held it in 4 quarters.
Maplelane Capital's IPG Photonics position peaked at $0 in Q3 2019.
427 funds tracked by Wall St. Rank held IPG Photonics as of Q4 2019.

Based on Maplelane Capital's 13F filing for Q4 2019, filed 14 Feb 2020.